| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в січні 1995 (uk)
- article scientifique publié en 1995 (fr)
- im Jahr 1995 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 1995 (ast)
- artikull shkencor i botuar më 01 janar 1995 (sq)
- scientific article published on 01 January 1995 (en)
|
| publication date
| |
| publication date
| |
| author name string
| |
| author name string
| - S A Waldman
- G Lewis
- M R Goldberg
- T D Bjornsson
- T E Bradstreet
- B Osborne
- W K Tanaka
- E J McWilliams
- L Pivadori
- S Lipert
|
| rdfs:label
| - Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (en)
- Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (nl)
- Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (sq)
|
| skos:prefLabel
| - Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (en)
- Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (nl)
- Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (sq)
|
| name
| - Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (en)
- Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (nl)
- Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (sq)
|
| title
| |
| title
| - Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| is about
of | |
| is cites work
of | - Clinical pharmacokinetics of losartan
- Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension
- The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis
- Pharmacokinetics and blood pressure response of losartan in end-stage renal disease
- Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist
- Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV
- Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension
- Drug-induced hyperkalemia: old culprits and new offenders
- Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis
- Angiotensin receptor antagonists: focus on losartan
- Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy
- Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism
- Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.
- Role of Angiotensin II AT1 Receptor Blockers in the Treatment of Arterial Hypertension
- Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense
- Effects of candesartan on electrical remodeling in the hearts of inherited dilated cardiomyopathy model mice
- Modulation of haemodynamics, endogeneous antioxidant enzymes, and pathophysiological changes by selective inhibition of angiotensin II type 1 receptors in pressureoverload rats
- Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists and calcium channel blocking agents: a review of potential benefits and possible adverse reactions
- Molecular biology of angiotensin receptors and their role in human cardiovascular disease
- Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure
- Effect of losartan on afferent nerve stimulation
- Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone
- Angiotensin receptors: physiology and pharmacology
- Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease
- Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients
- A risk-benefit assessment of losartan potassium in the treatment of hypertension
- Modulation of arterial thrombosis by angiotensin-converting enzyme inhibition and angiotensin II type 1-receptor blockade
- Apoptosis after reperfused myocardial infarction: Role of angiotensin II.
- DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan
- Losartan and angina pectoris.
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)